Dispositional mindfulness, affect and tobacco dependence among treatment naive cigarette smokers in Brazil
More details
Hide details
Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil
Hospital Israelita Albert Einstein, São Paulo, Brazil
Departamento de Psicologia, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil
School of Graduate Psychology, Pacific University, Hillsboro, United States
Department of Preventive Medicine and Public Health, School of Medicine, University of Kansas, Kansas City, United States
Isabel Weiss de Souza   

Departamento de Psicobiologia, Universidade Federal de São Paulo, Rua Botucatu 862, 1º andar, Edifício Ciências Biomédicas, Vila Clementino, 04023062 São Paulo, SP, Brazil
Publish date: 2019-04-08
Tob. Induc. Dis. 2019;17(April):28
The current study examined associations between affective and smoking-related factors, and dispositional mindfulness among smokers seeking enrollment in a cessation program in Brazil.

Participants were first-time treatment seeking adult smokers (N=90) on a waiting list for a government-sponsored cessation program. Pearson’s bivariate correlations assessed relationships between the primary outcome variable (dispositional mindfulness) and each explanatory variable (nicotine dependence, depression, anxiety, and state positive/negative affect). Linear regression analyses evaluated the unique contribution of each explanatory variable when controlling for the others.

The sample (N=90) was predominantly female (n=71) and most (79%) had 11 or fewer years of education. In the final regression model, a total of 36.2% of the variance in dispositional mindfulness was accounted for by positive affect (B=0.81, p<0.001), negative affect (B= -0.44, p=0.02), and level of nicotine dependence (B=1.48, p=0.007).

Positive and negative affect, as well as nicotine dependence, account for a significant and sizable amount of the variance in dispositional mindfulness. Future mindfulness interventions for smoking cessation should be designed to address individual differences in affect, as well as nicotine dependence, in order to better tailor treatment to address baseline differences in mindfulness.

We are grateful to SECOPTT, the service of tobacco treatment of the City Hall of Juiz de Fora (MG), and the Núcleo de Pesquisa sobre Saúde e Uso de Substâncias (Center of Research on Health and Substance Use -Nepsis/Unifesp) for the support provided to our research team during the study, and to the Department of Psychology of the Universidade Federal de Juiz de Fora (UFJF) for their collaboration in allowing Psychology undergraduate students to contribute with data collection, data bank construction and data analyses.
Authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
This work was supported by Public call MCT/CNPq/MEC/CAPES (Transverse action nº 06/2011); Casadinho/Procad (Process nº 552452/2011-4); Programa de Apoio a Núcleos Emergentes de Pesquisa (PRONEM)/FAPEMIG (Process nº APQ-04279-10); Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) – Project ‘Avaliação da efetividade do Programa de Mindfulness-Based Relapse Prevention (MBRP) como estratégia adjunta ao tratamento da dependência de tabaco’ (Process nº 2013/02316-5); Development line – Regular programs/research aid (Duration: 01/10/2013 – 30/09/2015); Doctoral Fellowship CNPq (Project nº 870470/1997-3 – Process nº 141310/2013- 8, Duration: 01/03/2013 – 31/01/2016).
IWS conceptualized the project, elaborated the project, collected and analyzed data, and elaborated the main text. EHK has helped elaborate the project, gave important suggestions on results, discussion of results and contributed for elaboration of the main text. LAR has helped elaborate the project and with data acquisition and analysis, discussion of results and prepared the tables. BM has helped with data acquisition. SB has helped elaborate the project, discussion of results, gave important suggestions on results, contributed for elaboration of the main text and revised the text for English grammar. KPR has helped elaborate the project, discussion of results, gave important suggestions on results, contributed for elaboration of the main text and revised the text for English grammar. LMAS helped elaborate the experimental design, helped with data acquisition and analysis, and main text elaboration, and gave important suggestions on results and discussion. ARN has coordinated and contributed to elaborate the project and experimental design, helped with bibliographical revision, helped with all the statistical analyses, discussion of results and main text review.
Not commissioned; externally peer reviewed.
World Health Organization. WHO Global Report. Mortality attributable to tobacco. Updated 2004. Accessed February 23, 2019.
World Health Organization. Tobacco control can save billions of dollars and millions of lives. Published January 10, 2017. Accessed February 25, 2019.
Piné-Abata H, McNeill A, Murray R, Bitton A, Rigotti N, Raw M. A survey of tobacco dependence treatment services in 121 countries: Tobacco treatment services in 121 countries. Addiction. 2013;108:1476-1484. doi:10.1111/add.12172.
World Health Organization. WHO Framework Convention on Tobacco Control. Geneva: WHO; 2003.
Cook JW, Collins LM, Fiore MC, et al. Comparative effectiveness of motivation phase intervention components for use with smokers unwilling to quit: a factorial screening experiment. Addiction. 2015;111:117-128. doi:10.1111/add.13161.
West R, Raw M, McNeill A, et al. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development: Health-care interventions: tobacco cessation. Addiction. 2015;110:1388-1403. doi:10.1111/add.12998.
GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet. 2017;389:1885-1906. doi:10.1016/S0140-6736(17)30819-X.
Ministério da Saúde, Instituto Nacional de Câncer. Abordagem e Tratamento do Fumante - Consenso 2001. Rio de Janeiro: Inca; 2001. Accessed August 25, 2018.
Levy D, Almeida LM, Szklo A. The Brazil SimSmoke Policy Simulation Model: The Effect of Strong Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths in a Middle Income Nation. PLoS Med. 2012;9:e1001336. doi:10.1371/journal.pmed.1001336.
Vidrine JI, Businelle MS, Cinciripini P, et al. Associations of Mindfulness with Nicotine Dependence, Withdrawal, and Agency. Subst Abuse. 2009;30:318-327. doi:10.1080/08897070903252973.
Kober H, Brewer JA, Height KL, Sinha R. Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments. NeuroImage. 2017;151:4-13. doi:10.1016/j.neuroimage.2016.09.042.
Garland EL, Howard MO. Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research. Addict Sci Clin Pract. 2018;13. doi:10.1186/s13722-018-0115-3.
Vidrine JI, Spears CA, Heppner WL, et al. Efficacy of mindfulness-based addiction treatment (MBAT) for smoking cessation and lapse recovery: A randomized clinical trial. J Consult Clin Psychol. 2016;84:824-838. doi:10.1037/ccp0000117.
Maglione MA, Maher AR, Ewing B, et al. Efficacy of mindfulness meditation for smoking cessation: A systematic review and meta-analysis. Addict Behav. 2017;69:27-34. doi:10.1016/j.addbeh.2017.01.022.
Brown KW, Ryan RM. The benefits of being present: Mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003;84:822-848. doi:10.1037/0022-3514.84.4.822.
Heppner WL, Spears CA, Correa-Fernández V, et al. Dispositional Mindfulness Predicts Enhanced Smoking Cessation and Smoking Lapse Recovery. Ann Behav Med. 2016;50:337-347. doi:10.1007/s12160-015-9759-3.
Brewer JA, Mallik S, Babuscio TA, et al. Mindfulness training for smoking cessation: Results from a randomized controlled trial. Drug Alcohol Depend. 2011;119:72-80. doi:10.1016/j.drugalcdep.2011.05.027.
Davis JM, Manley AR, Goldberg SB, Smith SS, Jorenby DE. Randomized trial comparing mindfulness training for smokers to a matched control. J Subst Abuse Treat. 2014;47:213-221. doi:10.1016/j.jsat.2014.04.005.
Brewer JA, Bowen S, Smith JT, Marlatt GA, Potenza MN. Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain? Addiction. 2010;105:1698-1706. doi:10.1111/j.1360-0443.2009.02890.x.
Witkiewitz K, Bowen S. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. J Consult Clin Psychol. 2010;78:362-374. doi:10.1037/a0019172.
Barros VV, Kozasa EH, Formagini TDB, Pereira LH, Ronzani TM. Smokers Show Lower Levels of Psychological Well-Being and Mindfulness than Non-Smokers. PLOS ONE. 2015;10:e0135377. doi:10.1371/journal.pone.0135377.
Paulus DJ, Langdon KJ, Wetter DW, Zvolensky MJ. Dispositional Mindful Attention in Relation to Negative Affect, Tobacco Withdrawal, and Expired Carbon Monoxide On and After Quit Day. J Addict Med. 2017;1. doi:10.1097/ADM.0000000000000361.
Carmo JT, Pueyo AA. A adaptaçäo ao português do Fagerström test for nicotine dependence (FTND) para avaliar a dependência e tolerância à nicotina em fumantes brasileiros. RBM Rev Bras Med. 2002;59:73-80. Accessed May 18, 2018.
Botega NJ, Bio MR, Zomignani MA, Garcia Jr C, Pereira WAB. Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Rev Saúde Pública [Mood disorders among medical in-patients: a validation study of the hospital anxiety and depression scale (HAD)]. 1995;29:359-363. doi:10.1590/S0034-89101995000500004.
Barros VV, Kozasa EH, Souza ICW, Ronzani TM. Validity evidence of the brazilian version of the five facet mindfulness questionnaire (FFMQ). Psicol Teor E Pesqui. 2014;30:317-327. doi:10.1590/S0102-37722014000300009.
Carvalho HW, Andreoli SB, Lara DR, et al. Structural validity and reliability of the Positive and Negative Affect Schedule (PANAS): Evidence from a large Brazilian community sample. Rev Bras Psiquiatr. 2013;35:169-172. doi:10.1590/1516-4446-2012-0957.
Etcheverry PE, Waters AJ, Lam C, et al. Attentional bias to negative affect moderates negative affect’s relationship with smoking abstinence. Health Psychol. 2016;35:881-890. doi:10.1037/hea0000338.
Andreu CI, Cosmelli D, Slagter HA, Franken IHA. Effects of a brief mindfulness-meditation intervention on neural measures of response inhibition in cigarette smokers. PLOS ONE. 2018;13:e0191661. doi:10.1371/journal.pone.0191661.
Tang YY, Posner MI, Rothbart MK, Volkow ND. Circuitry of self-control and its role in reducing addiction. Trends Cogn Sci. 2015;19:439-444. doi:10.1016/j.tics.2015.06.007.
Vidrine JI, Spears CA, Heppner WL, et al. Efficacy of mindfulness-based addiction treatment (MBAT) for smoking cessation and lapse recovery: A randomized clinical trial. J Consult Clin Psychol. 2016;84:824-838. doi:10.1037/ccp0000117.
Glasner S, Mooney LJ, Ang A, et al. Mindfulness-Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial. Mindfulness. 2017;8:126-135. doi:10.1007/s12671-016-0586-9.
Grant S, Colaiaco B, Motala A, et al. Mindfulness-based Relapse Prevention for Substance Use Disorders: A Systematic Review and Meta-analysis. J Addict Med. 2017;11:386-396. doi:10.1097/ADM.0000000000000338.
Sancho M, De Gracia M, Rodríguez RC, et al. Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review. Front Psychiatry. 2018;9. doi:10.3389/fpsyt.2018.00095.
Prochaska JJ. Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction? Drug Alcohol Depend. 2010;110:177-182. doi:10.1016/j.drugalcdep.2010.03.002.
Tiffany ST. A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes. Psychol Rev. 1990;97:147-168. doi:10.1037/0033-295X.97.2.147.